TRANSCRIPT

Q2 2020 — Earnings call remarks

Q2 2020PDF · 10 pages204 KB
1
Second Quarter 2020 Prepared Remarks
July 15, 2020
Moderator:
Good morning, and welcome to the UnitedHealth Group Second Quarter 2020 Earnings Conference Call.
A question and answer session will follow UnitedHealth Group’s prepared remarks. As a reminder, this
call is being recorded.
Here is some important introductory information. This call contains “forward-looking” statements under
U.S. federal securities laws. These statements are subject to risks and uncertainties that could cause
actual results to differ materially from historical experience or present expectations. A description of
some of the risks and uncertainties can be found in the reports that we file with the Securities and
Exchange Commission, including the cautionary statements included in our current and periodic filings.
This call will also reference non-GAAP amounts. A reconciliation of the non-GAAP to GAAP amounts is
available on the “Financial & Earnings Reports” section of the Company’s Investor Relations page at
www.unitedhealthgroup.com.
Information presented on this call is contained in the Earnings Release we issued this morning and in our
Form 8-K dated July 15, 2020, which may be accessed from the Investor Relations page of the
Company’s website. I will now turn the conference over to the chief executive officer of UnitedHealth
Group, David Wichmann.
Dave Wichmann
Good morning and thank you for joining us. When we last met in this forum 90 days
ago, the challenges of COVID-19 in the Americas were just beginning to emerge. Now,
some four months into the evolving pandemic, the individual, health system, social and
economic implications of the virus are better understood and significant … especially,
the impact of long-standing health disparities affecting the underserved populations hit
hardest by the pandemic.
In uncharted periods such as these, we lean on our mission and cultural values to guide
us. That mission and those values call on us to:
• help people,

-- 1 of 10 --

2
• to help health systems …
• to help everyone …
• with integrity, compassion, innovation, relationships and performance.
I am grateful to – and proud of – our 325,000 diverse team members as they continue to
provide vital support. Caring for those we serve and working with the health system
partners to combat this disease and the many other daily health challenges that have
not gone away. They’ve just been deferred, and possibly become more complicated.
We deeply appreciate the tireless service of our 120,000 doctors, nurses, medical and
behavioral professionals, social workers, pharmacists and other health care workers on
the front lines of care. They serve in Brazil, Chile, Colombia, Peru and Portugal. They
serve in New York City, Seattle, Southern California, Phoenix, Texas, Florida and other
communities confronted by COVID-19. Their compassion for our patients and members
has saved lives and helped make the lives of countless other people better.
UnitedHealth Group was built to be adaptable – an instinctive enterprise capable of
anticipating change, rapidly evolving and reconfiguring capabilities to meet both
challenges and opportunities. The past several months have only highlighted the
importance of this agility, so long core to how we operate, and deepened our resolve to
cultivate it. We’ve witnessed our people helping in ways and advancing innovations and
solutions at an unprecedented pace, scope and scale.
Today, I’d like to provide insights into how:
• our business is both responding and advancing;
• share what we’ve learned in the past several months;
• describe how these lessons enhance our ability to serve even more people, more
deeply, and as a result;
• we expect to grow and emerge stronger in the years to come.

-- 2 of 10 --

3
UnitedHealthcare and Optum have both experienced the effects of an unprecedented
decline in health care services. Among early actions we undertook to help people were:
• opening new enrollment periods, so more people could be covered;
• waiving all consumer COVID-19 diagnostic and treatment costs;
• accelerating $2 billion in needed funding to care providers, and;
• providing over $1.5 billion in direct consumer and customer assistance, including
premium forgiveness and suspension of member cost sharing, to help people
manage their health conditions.
These amounts are in addition to the $1 billion in estimated rebates to be paid in coming
periods.
Throughout this pandemic, we have taken extraordinary measures to ensure people get
the essential care they need. As we speak with you today, care access patterns are
nearing more normal levels, an encouraging sign for people’s health. We see the
system operating just short of its normal baseline now, far above the lows experienced
as the second quarter began. We currently expect care access patterns – while
somewhat more volatile than in the past – to moderately exceed normal baselines in the
second half, as people seek previously deferred care. And the pandemic, with high
testing and treatment costs per affected consumer, is expected to continue to run its
course throughout 2020 and into 2021.
Consistent with the proactive actions we have already undertaken, we will continue to
act swiftly to address any further financial imbalances arising from the pandemic and
related effects.
We are further advancing broad health equity initiatives, tapping into our data,
information and analytics capacities to guide scientific efforts to help eliminate long-
standing health disparities. This is a course we have pursued for many years and are
now even more intentional, as we see underserved populations disproportionally
impacted by this health crisis.

-- 3 of 10 --

4
We established an innovative, community-based care model to provide COVID-19
testing, education and other necessary services to some of the highest-risk and least-
served communities in the country. We are focusing on locations with high mortality,
along with local community challenges including poverty, crowding, food insecurity,
homelessness and other existing social determinants of health. Our service includes
special deployments in the underserved communities of Philadelphia, Los Angeles and
Orleans Parish, alongside many other similar communities we serve through our core
Medicare and Medicaid programs.
We are researching new treatment approaches in partnership with prominent academic
institutions. For example, working with the Morehouse School of Medicine, we’re
studying the effect of COVID-19 on those with sickle cell trait, a condition which is
prevalent in 8 to 10% of Black Americans.
We’re conducting an ACE inhibitor virtual clinical trial with the Yale School of Medicine.
Artificial intelligence applied to our data showed that seniors on ACE inhibitors who test
positive for COVID-19 are 40% less likely to need hospitalizations than those who are
not. Understanding that there is significant racial disparity in the use of ACE inhibitors to
manage hypertension, we’re working to rapidly scale this 10,000-person, virtual clinical
trial, believed to be the first of its type.
We’re partnering with a growing number of state governments and employers who are
using Optum’s rapid response resources to stand up mobile and fixed testing sites. To
date we’ve helped conduct more than a half million tests across more than 500 sites,
most often in rural and underserved communities.
We committed another $100 million in affordable housing to address homelessness,
bringing our total investments to more than $500 million, to build nearly 5,400 units over
the past seven years.

-- 4 of 10 --

5
And we will do more, focused on working with others, to eradicate long-standing health
disparities in America and to create a more diverse U.S. health workforce.
The COVID-19 crisis has accelerated the adoption of new technologies and approaches
to care. We’re serving people where they want to be served – and more often in the
home, which is becoming a preferred additional care setting through new, innovative
digital offerings. At peak care system closure in April, UnitedHealthcare facilitated more
than 4 million digital care visits. That’s nearly 30-times the number of visits we enabled
in January.
We expect digital and home care to persist and expand in coming years. We are rapidly
assembling our next-generation, comprehensive platform leveraging:
• the digital signaling and monitoring capacities of Vivify,
• the market-leading engagement capabilities of Rally,
• our AI-enabled, Individual Health Record,
• the pharmacy e-Commerce capabilities of OptumRx,
• our extensive, hands-on community based clinical resources and, importantly,
• a proprietary, scalable direct to your own doctor telemedicine platform.
The understandable and expected rise in stress, anxiety and social isolation has
increased the demand for behavioral health services. Digital platforms are proving to be
increasingly effective in remotely diagnosing and caring for people with such needs,
with a rapidly expanding scope. Optum is among the largest providers of digital
behavioral health care services in the country, now with more than 10,000 care
providers using our virtual visit platform. Our digital psychiatry offerings extend to
community behavioral health clinics, enabling hundreds of thousands of digital visits and
complements our more than 500 community based behavioral health pharmacies.
Optum nurses are meeting the increasing need for infusion services in the comfort and
safety of people’s homes, a double-digit trend we expect will accelerate for years to

-- 5 of 10 --

6
come. Home infusion visits by our nurses offer fully equivalent clinical efficacy, greater
patient convenience and satisfaction and reduced risk of immuno-compromised
people … at up to one-half the cost of traditional settings. And our HouseCalls services
include extensive digital clinical care visits, supplementing in-home visits by Optum
nurses.
As clinical techniques and technologies advance, ambulatory surgical care is expanding
as an appropriate care setting for high acuity members and procedures, like
cardiovascular surgeries. Partly as a result of the COVID-19 disruptions, the
convenience, safety and better patient and surgeon experience is becoming more
deeply understood. For example, in just the last two months, we welcomed several
hundred new surgeons to our centers and have opened new and higher acuity service
lines.
We expect the alignment of physicians to value-based care models to accelerate. The
recent months have served as a compelling example of why care delivery has and
should continue to advance in this direction. OptumCare continues as the physician
partner of choice, with over 6,500 additional clinicians – primarily PCPs, specialists,
nurse practitioners and physicians’ assistants – added so far this year. These clinicians
are seeking alignment with the entity best equipped to help move to high-performing,
and more stable, accountable care models. We believe that entity is OptumCare.
These are a few examples of how we have and continue to innovate to help make
people healthier and to help make health systems work better for everyone. The
information and technology enabled ambulatory care and pharmacy capacities of
Optum, leveraged and deployed by UnitedHealthcare and other payers and other health
systems, hold significant promise for the future of the U.S. health system.
Now I’ll turn it over to Chief Financial Officer, John Rex.

-- 6 of 10 --

7
John Rex – Financial Discussion
Thank you, Dave. As expected, our second quarter earnings were meaningfully
impacted by unprecedented and far reaching disruption in care patterns. We expect this
temporary impact will be offset in the quarters ahead by the proactive assistance
measures we have already taken, the resumption of more normal care patterns and
future COVID-19 impacts, both within the health care sector and the economy at large.
Looking more specifically at the pandemic effects in the second quarter: Optum revenue
and earnings for fee-for-service care delivery, and the OptumInsight and OptumRx
volume-based businesses, were reduced by lower level of care encounters. For the
Company as a whole, this was more than offset by the disrupted care patterns within
the UnitedHealthcare and the OptumHealth risk-based businesses.
Prior period development of $1.4 billion arose primarily from the lower than expected
care levels in the second half of March, contributing to the lower medical care ratio this
quarter.
The impact of this care disruption is reduced by factors such as COVID related
treatment and testing and the financial assistance we are providing. Notably, the
assistance component has a more pronounced financial impact in future periods. For
example, the suspension of member cost share will have an accelerating benefit, and
corresponding impact, for the people we serve as care delivery systems further reopen
and they seek care again.
At the lowest point in April, inpatient care – inclusive of COVID-19 related care – was
about three quarters of baseline. In June, this recovered to nearly 95%. At the same
lowest point, outpatient and physician services fell to roughly 60% of normal levels. As
we exited June, they were also recovering, tracking above 90%. These national trends
have continued thus far in July, even as certain states are seeing short-term deferral of
services where there are elevated levels of infection and hospitalization.

-- 7 of 10 --

8
Turning to Optum’s overall performance, each of the three businesses performed well,
while they were affected in different ways by care deferral and the economic downturn.
OptumHealth’s second quarter earnings increased 22% year-over-year. The impact of
the lower patient visits in fee-for-service practices was mostly offset by the same
temporary deferral of care effects on the risk-bearing practices.
OptumInsight second quarter earnings increased 7% year-over-year, while the revenue
backlog grew by nearly $1 billion to $19.4 billion. Many of OptumInsight’s payer and
care provider clients have volume-based contracts for technology and managed
services. After an expected slowing of such volumes early in the second quarter due to
care deferral, we are now seeing activity rebound. And we see the new business
pipeline strengthening again as evidenced by the new partnership with Boulder
Community Health.
OptumRx earnings declined by 6% year-over-year in the second quarter, as script
volumes were impacted by lower care activity. Unsurprisingly, given the sharp drop in
primary care and specialist visits, first fills of prescriptions declined by about one-third
early in the second quarter, but began to recover as the quarter progressed and have
continued to do so, as care activity increases.
Turning to UnitedHealthcare, second quarter operating earnings were significantly
higher due to the temporary care deferrals. We continue to serve more people through
our public-sector and senior businesses, including an increase through the second
quarter of nearly 600,000 people year-to-date. As expected, given the economic
climate, commercial enrollment declined, albeit at lower levels than the change in
unemployment might have suggested, as many employers continued benefits coverage
for furloughed employees.
During the second quarter, growth in sales of individual policies and Medicaid
membership accelerated, the latter as states eased redetermination requirements to

-- 8 of 10 --

9
ensure sustainable coverage for people. We were also awarded contracts to serve
Medicaid members in Kentucky in 2021, are honored to have been selected to serve the
Medicaid population in Indiana and are pleased to continue serving in Philadelphia.
After a strong annual enrollment period for Medicare Advantage, the pacing of new
enrollees in April and May eased as traditional in-person sales slowed. In recent weeks,
sales have accelerated, with the current level of Medicare Advantage enrollment activity
having rebounded to pre-COVID-19 expectation levels.
Our liquidity and financial position have remained strong. Second quarter cash flows
reached $10 billion, or 1.5 times net earnings. Both cash flows and days in claims
payables were impacted by the swift moves we undertook to provide enhanced liquidity
by accelerating payments to individual care providers and health systems. Offsetting
this impact was the timing of second quarter income tax payments, which will now occur
in the third quarter.
As noted in our press release this morning, we are maintaining our full year earnings
per share outlook in anticipation of the delivery of previously deferred – and potentially
even higher acuity care, as well as continued costs to address COVID-19 in the second
half of the year. We are encouraged by the rapid pacing of the reopening of care
delivery systems and are proactively working to help people quickly obtain the care they
need.
In addition, we incorporate a second half view for a more pronounced impact from the
consumer, customer and care provider assistance initiatives already undertaken. As
Dave stated, we will act to address further imbalances should they arise, over the
duration of this pandemic.
With that, I’ll turn it back to Dave.

-- 9 of 10 --

10
Dave Wichmann – Closing Remarks
Thank you, John.
Today, in the midst of the COVID-19 crisis, foremost on our minds is the safety of our
team members and their families, and the need to continue adapting rapidly, innovating
and delivering for those we serve. Still, we know you begin to focus at this time on what
will come in 2021 and beyond.
At this distance, the evolution of the pandemic, when, and to what extent the economy
will improve, are very much open questions. We expect the macroeconomic impacts of
the broader unemployment and actions we have taken to assist customers and
communities to continue well into next year. Helping our customers through an
unexpected macro environment and the extended impact from disruptions in care has
and will continue to be an area of intense focus for our business leaders and care
providers.
During this period, our diversified businesses are creating unique opportunities to
serve – and we don’t believe these are just passing trends. They bring:
• more effective clinical outcomes, satisfaction and convenience for people, at lower
cost …
• a significant contribution to the next-generation health system …
• one that operates in a socially conscious way.
These are accelerating and durable trends, well supportive of our 13 to 16% long-term
growth objective in the years to come. Public-sector and senior benefits programs, our
care delivery businesses, our digital and home-based initiatives, pharmacy care
services, data and analytics, and health banking and payments platforms will continue
contributing as significant growth factors, long into the future.
Thank you.

-- 10 of 10 --